LEXINGTON, Mass.--(BUSINESS WIRE)--June 22, 2006--Predix Pharmaceuticals, which recently announced a definitive agreement to merge with EPIX Pharmaceuticals (NASDAQ: EPIX - News), announced today that data featuring select drug candidates currently in clinical development will be the subject of presentations at major medical and scientific meetings in the next few weeks.
